Daniel Levitt

2014

In 2014, Daniel Levitt earned a total compensation of $1.4M as Executive Vice President and Chief Medical Officer at CytRx, a 38% decrease compared to previous year.

Compensation breakdown

Bonus$300,000
Option Awards$602,000
Salary$525,000
Total$1,427,000

Levitt received $602K in option awards, accounting for 42% of the total pay in 2014.

Levitt also received $300K in bonus and $525K in salary.

Rankings

In 2014, Daniel Levitt's compensation ranked 5,996th out of 13,032 executives tracked by ExecPay. In other words, Levitt earned more than 54.0% of executives.

ClassificationRankingPercentile
All
5,996
out of 13,032
54th
Division
Manufacturing
2,170
out of 4,966
56th
Major group
Chemicals And Allied Products
722
out of 1,686
57th
Industry group
Drugs
561
out of 1,365
59th
Industry
Biological Products, Except Diagnostic Substances
103
out of 236
56th
Source: SEC filing on May 20, 2016.

Levitt's colleagues

We found four more compensation records of executives who worked with Daniel Levitt at CytRx in 2014.

2014

Steven Kriegsman

CytRx

Chief Executive Officer

2014

Scott Wieland

CytRx

Senior Vice President – Drug Development

2014

John Caloz

CytRx

Chief Financial Officer

2014

Benjamin Levin

CytRx

General Counsel

You may also like